QT Imaging Holdings, Inc. has published an updated investor presentation to its website and filed it with the SEC. The presentation provides supplemental product and operational information regarding the company's Breast Acoustic CT Scanner technology. The filing is intended to provide current and potential investors with strategic highlights and technical details of the company's imaging platform.
QTI reported strong 75% revenue growth but lowered 2026 guidance due to Middle East shipping delays, partially offset by a major CMS reimbursement milestone.
QT Imaging Holdings reported significant revenue growth for the nine months ended September 30, 2026, reaching $21.3 million compared to $10.7 million in 2025. Despite this, the company incurred a net loss of $14.8 million, driven by increased operating expenses and a $8.3 million loss on debt extinguishment and modification.
QT Imaging reported Q3 2026 revenue of $7.3 million, a 75% year-over-year increase, driven by the sale of 15 Breast Acoustic CT scanners. The company achieved a major regulatory milestone with CMS establishing a Medicare hospital outpatient payment pathway for diagnostic QTscan examinations effective January 1, 2027. Full-year 2026 revenue guidance was adjusted to approximately $34 million due to international shipment delays caused by conflict in the Middle East.
Term
Q3 2026
“Our third-quarter results demonstrate the continued growth of QT Imaging, with revenue increasing 75% year over year and reaching $21.3 million for the first nine months of 2026, approximately double the prior-year period.”
Dr. Raluca Dinu, Chief Executive Officer of QT Imaging
“A major milestone is the recent CMS decision establishing separate Medicare hospital outpatient payment for medically necessary diagnostic QTscan examinations, effective January 1, 2027. Together with our dedicated billing code, effective October 1, this decision removes a significant reimbursement uncertainty and strengthens our ability to expand into U.S. hospitals and health systems.”
Dr. Raluca Dinu, Chief Executive Officer of QT Imaging